Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 20,955 shares at $0.24 ($5K) on 2019-09-04, disclosed to the SEC on 2019-09-06.
Open-market purchase of $5k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.24 | 2,500 | $600 | 11.9% |
| 2 | $0.24 | 18,455 | $4K | 88.1% |
| Total | $0.24 avg | 20,955 | $5K | 100% |
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |